IRADIMED CORPORATION Announces the Appointment of Lynn Neuhardt as Vice President of Research and Development
iRadimed Corporation (IRMD)
Last iradimed corporation earnings: 4/30 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
iradimed.com/en-us/investors/investor-contact
Company Research
Source: GlobeNewswire
WINTER SPRINGS, Fla., March 12, 2020 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced the appointment of Lynn Neuhardt as Vice President of Research and Development, effective March 26, 2020. Mr. Neuhardt will report to Leslie McDonnell, President and Chief Executive Officer. “Lynn is an experienced R&D leader with deep knowledge in the development of IV infusion pumps. Lynn will lead our talented R&D team and collaborate closely with Roger Susi, our founder and Chief Technology Officer. I am confident his leadership and direct contributions to our current and future products will help drive our continued success. We are excited to add him to the executive team,” said McDonnell. About Lynn Neuhardt Mr. Neuhardt has extensive experience in the medical technology industry and specifically with IV infusion pumps. Prior to his appointment at IRADIMED, Mr. Neuhardt spent 4 years at ICU Medical, Inc. as a Director of Systems and Test Engineering. Prior to that, M
Show less
Read more
Impact Snapshot
Event Time:
IRMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IRMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IRMD alerts
High impacting iRadimed Corporation news events
Weekly update
A roundup of the hottest topics
IRMD
News
- IRADIMED CORPORATION to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
- Should You Investigate IRADIMED CORPORATION (NASDAQ:IRMD) At US$54.43? [Yahoo! Finance]Yahoo! Finance
- IRADIMED CORPORATION on Forbes' List of America's Most Successful Small-Cap Companies for 2025 [Yahoo! Finance]Yahoo! Finance
- IRADIMED CORPORATION on Forbes’ List of America’s Most Successful Small-Cap Companies for 2025GlobeNewswire
- Is There An Opportunity With IRADIMED CORPORATION's (NASDAQ:IRMD) 47% Undervaluation? [Yahoo! Finance]Yahoo! Finance
IRMD
Earnings
- 10/31/24 - Beat
IRMD
Sec Filings
- 12/13/24 - Form 4
- 12/13/24 - Form 4
- 12/13/24 - Form 4
- IRMD's page on the SEC website